These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3494064)

  • 1. Differential antigen-presenting cell requirements of hapten-specific T cell lines restricted to class II determinants.
    Hanke JH; Cook RG; Lopez LA; Rich RR
    J Immunol; 1987 Apr; 138(8):2384-91. PubMed ID: 3494064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential presentation of HLA-DR, DQ, and DP restriction elements by interferon-gamma-treated dermal fibroblasts.
    Maurer DH; Hanke JH; Mickelson E; Rich RR; Pollack MS
    J Immunol; 1987 Aug; 139(3):715-23. PubMed ID: 3110281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Requirement of Ia-positive accessory cells in the MLR response against class II antigen on human B cell tumor line.
    Yamamoto M; Yano A
    J Immunol; 1985 Dec; 135(6):3887-96. PubMed ID: 2999233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigen presentation by interferon-gamma-treated endothelial cells and fibroblasts: differential ability to function as antigen-presenting cells despite comparable Ia expression.
    Geppert TD; Lipsky PE
    J Immunol; 1985 Dec; 135(6):3750-62. PubMed ID: 3934267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigen-specific and polyclonal immunoglobulin production induced by a cloned tetanus toxoid-specific T cell line.
    Friedman SM; Principato MA; Thompson GS; Teichman F
    J Immunol; 1983 Mar; 130(3):1164-70. PubMed ID: 6185573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activated T cells and monocytes have characteristic patterns of class II antigen expression.
    Robbins PA; Maino VC; Warner NL; Brodsky FM
    J Immunol; 1988 Aug; 141(4):1281-7. PubMed ID: 3135327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD40-stimulated B lymphocytes pulsed with tumor antigens are effective antigen-presenting cells that can generate specific T cells.
    Lapointe R; Bellemare-Pelletier A; Housseau F; Thibodeau J; Hwu P
    Cancer Res; 2003 Jun; 63(11):2836-43. PubMed ID: 12782589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of HLA class II antigens in fetal human spleen: relationship of HLA-DP, DQ, and DR to immunoglobulin expression.
    Edwards JA; Durant BM; Jones DB; Evans PR; Smith JL
    J Immunol; 1986 Jul; 137(2):490-7. PubMed ID: 3522732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The selective antigen-presenting cell capacity of activated B lymphocytes in HLA-II-restricted responses of CD4+ T lymphocytes.
    Van Der Pouw Kraan TT; Stiekema FE; Teunissen MB; Bos JD; Kapsenberg L
    Immunology; 1989 Oct; 68(2):147-53. PubMed ID: 2572541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of class II major histocompatibility complex molecules on antigen-presenting cells by antibody fragments.
    Vidović D; Falcioni F; Siklodi B; Belunis CJ; Bolin DR; Ito K; Nagy ZA
    Eur J Immunol; 1995 Dec; 25(12):3349-55. PubMed ID: 8566022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hybrid cells formed by fusion of Epstein-Barr virus-associated B-lymphoblastoid cells and either marrow-derived or solid tumour-derived cell lines display different co-stimulatory phenotypes and abilities to activate allogeneic T-cell responses in vitro.
    Cywinski AL; Dunnion DJ; Teobald I; Tucker VC; Browning MJ
    Tissue Antigens; 2006 Aug; 68(2):115-26. PubMed ID: 16866881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [CD4+T cells restricted by DQ not by DR support CD8+T cells to grow].
    Kamikawaji N
    Fukuoka Igaku Zasshi; 1990 Feb; 81(2):88-96. PubMed ID: 2328939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-DP can be expressed with or without -DR molecules on a malignant B cell line.
    Pesando JM; Graf L; Hoffman P
    J Immunol; 1986 Sep; 137(6):1932-6. PubMed ID: 3489045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presentation of a soluble bacterial antigen and cell-surface alloantigens by large granular lymphocytes (LGL) in comparison with monocytes.
    Brooks CF; Moore M
    Immunology; 1986 Jul; 58(3):343-50. PubMed ID: 3488259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of class II HLA molecules in T cell activation by antigen. Implications for the autologous mixed lymphocyte reaction.
    Thorsby E; Berle E; Scott H; Braathen LR
    Behring Inst Mitt; 1983 May; (72):129-34. PubMed ID: 6100471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient presentation of known HLA class II-restricted MAGE-A3 epitopes by dendritic cells electroporated with messenger RNA encoding an invariant chain with genetic exchange of class II-associated invariant chain peptide.
    Bonehill A; Heirman C; Tuyaerts S; Michiels A; Zhang Y; van der Bruggen P; Thielemans K
    Cancer Res; 2003 Sep; 63(17):5587-94. PubMed ID: 14500399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bronchoalveolar cells from sarcoid patients demonstrate enhanced antigen presentation.
    Lem VM; Lipscomb MF; Weissler JC; Nunez G; Ball EJ; Stastny P; Toews GB
    J Immunol; 1985 Sep; 135(3):1766-71. PubMed ID: 3874905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients.
    Valli A; Sette A; Kappos L; Oseroff C; Sidney J; Miescher G; Hochberger M; Albert ED; Adorini L
    J Clin Invest; 1993 Feb; 91(2):616-28. PubMed ID: 7679413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel HLA class II-independent TCR-mediated T cell activation mechanism is distinguished by the V beta specificity of the proliferating oligoclones and their capacity to generate interleukin-2.
    Dennig D; Yan Y; Ferguson K; O'Reilly RJ
    Cell Immunol; 1996 Aug; 171(2):200-10. PubMed ID: 8806788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation requirements of cloned inducer T cells. II. The failure of some clones to respond to antigen presented by activated B cells.
    Dekruyff RH; Cantor H; Dorf ME
    J Immunol; 1986 Jan; 136(2):446-51. PubMed ID: 3484492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.